Usage: VYVGART is indicated for the treatment of generalized myasthenia gravis (gMG) in adult patients who test positive for anti-acetylcholine receptor (AChR) antibodies.
vyvgart hytrulo
(efgartigimod alfa and hyaluronidase (human recombinant))
argenx US
Usage: VYVGART HYTRULO is indicated for the treatment of adult patients with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive and chronic inflammatory demyelinating polyneuropathy (CIDP).